Hamers FP - Search Results

1

Ataxia with loss of Purkinje cells in a mouse model for Refsum disease.

Ferdinandusse S, Zomer AW, Komen JC, van den Brink CE, Thanos M, Hamers FP, Wanders RJ, van der Saag PT, Poll-The BT, Brites P. Ferdinandusse S, et al. Among authors: hamers fp. Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17712-7. doi: 10.1073/pnas.0806066105. Epub 2008 Nov 11. Proc Natl Acad Sci U S A. 2008. PMID: 19004801 Free PMC article.

2

Protection and spontaneous recovery from cisplatin-induced hearing loss.

Smoorenburg GF, De Groot JC, Hamers FP, Klis SF. Smoorenburg GF, et al. Among authors: hamers fp. Ann N Y Acad Sci. 1999 Nov 28;884:192-210. doi: 10.1111/j.1749-6632.1999.tb08642.x. Ann N Y Acad Sci. 1999. PMID: 10842594

3

Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord.

Ruitenberg MJ, Plant GW, Hamers FP, Wortel J, Blits B, Dijkhuizen PA, Gispen WH, Boer GJ, Verhaagen J. Ruitenberg MJ, et al. Among authors: hamers fp. J Neurosci. 2003 Aug 6;23(18):7045-58. doi: 10.1523/JNEUROSCI.23-18-07045.2003. J Neurosci. 2003. PMID: 12904465 Free PMC article.

4

Profound differences in spontaneous long-term functional recovery after defined spinal tract lesions in the rat.

Hendriks WT, Eggers R, Ruitenberg MJ, Blits B, Hamers FP, Verhaagen J, Boer GJ. Hendriks WT, et al. Among authors: hamers fp. J Neurotrauma. 2006 Jan;23(1):18-35. doi: 10.1089/neu.2006.23.18. J Neurotrauma. 2006. PMID: 16430370

5

Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose.

Klis SF, O'Leary SJ, Wijbenga J, de Groot JC, Hamers FP, Smoorenburg GF. Klis SF, et al. Among authors: hamers fp. Hear Res. 2002 Feb;164(1-2):138-46. doi: 10.1016/s0378-5955(01)00425-7. Hear Res. 2002. PMID: 11950533

6

Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity.

Wolters FL, de Vocht TF, Klis SF, Hamers FP, Smoorenburg GF. Wolters FL, et al. Among authors: hamers fp. Hear Res. 2002 Oct;172(1-2):110-7. doi: 10.1016/s0378-5955(02)00551-8. Hear Res. 2002. PMID: 12361873

7

Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.

Wolters FL, Klis SF, de Groot JC, Hamers FP, Prieskorn DM, Miller JM, Smoorenburg GF. Wolters FL, et al. Among authors: hamers fp. Hear Res. 2003 May;179(1-2):53-61. doi: 10.1016/s0378-5955(03)00080-7. Hear Res. 2003. PMID: 12742238

8

Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.

Wolters FL, Klis SF, Hamers FP, de Groot JC, Smoorenburg GF. Wolters FL, et al. Among authors: hamers fp. Hear Res. 2004 Mar;189(1-2):31-40. doi: 10.1016/S0378-5955(03)00396-4. Hear Res. 2004. PMID: 14987750

9

Reversible cisplatin ototoxicity in the albino guinea pig.

Klis SF, O'Leary SJ, Hamers FP, De Groot JC, Smoorenburg GF. Klis SF, et al. Among authors: hamers fp. Neuroreport. 2000 Feb 28;11(3):623-6. doi: 10.1097/00001756-200002280-00037. Neuroreport. 2000. PMID: 10718325

10

Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects.

O'Leary SJ, Klis SF, de Groot JC, Hamers FP, Smoorenburg GF. O'Leary SJ, et al. Among authors: hamers fp. Hear Res. 2001 Apr;154(1-2):135-45. doi: 10.1016/s0378-5955(01)00232-5. Hear Res. 2001. PMID: 11423224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters